Start: 29 September 2025
End: 1 October 2025

The annual TOPRA Symposium is aimed at professionals working in the field of regulatory affairs for medicinal products and medical devices, as well as experts from related disciplines. This international conference brings together participants from regulatory authorities, industry, science and academia, providing a platform for in-depth discussion of current regulatory developments in Germany and across Europe.

The 2025 Symposium in Berlin is hosted by TOPRA in partnership with the Federal Institute for Drugs and Medical Devices (BfArM), the Paul-Ehrlich-Institut – Federal Institute for Vaccines and Biomedicines (PEI), and the Federal Office of Consumer Protection and Food Safety (BVL).

Prof. Dr. Karl. Broich, President of BfArM, will officially open the symposium on 29 September 2025 at 11:45 a.m., together with Prof. (apl.) Dr. Stefan Vieths, President of PEI, and Dr. Samantha Atkinson, CEO of TOPRA.

Key Topics of the Conference:

• Innovations in the field of medicinal products and medical devices in Germany and Europe
• Insights into modern regulatory approaches and emerging technologies
• Current developments in authorisation and research frameworks
• Exchange with international experts from authorities, industry, academia and science.

An exclusive video statement by Prof. Dr. Karl Broich, President of Germany’s Federal Institute for Drugs and Medical Devices (BfArM), offers a preview of the key themes and objectives of the TOPRA Symposium 2025 in Berlin – with a particular focus on the context of the Medical Research Act. As a partner of the event, BfArM highlights the significance of the symposium for European health regulation.

Further details and the full programme are available on the official TOPRA website: TOPRA Symposium 2025